Portrait of M. Cristina Vazquez Guillamet, MD

M. Cristina Vazquez Guillamet, MD

Associate Professor of Medicine

Dr. M. Cristina Vazquez Guillamet is a core faculty member of the ID Fellowship Program and serves as Director of the ID/Critical Care Pathway. Her research focuses on infections caused by multidrug-resistant microbes in critically ill patients. Dr. Vazquez Guillamet uses new mathematical and machine learning algorithms to better understand, predict, and improve outcomes for ICU patients at risk for these infections.

Dr. Vazqeuz is especially interested in the epidemiology, treatment, and impact of multidrug-resistant infections. Her work aims to develop clear, practical tools that can identify patients at risk and support better clinical decision-making.

Related Links
Office location

Northwest Tower
4990 Children’s Place
St. Louis, MO 63110

Education
  • MD: University of Medicine and Pharmacy “Carol Davila”, Bucharest, Romania (2005)
  • MPH: University of Bucharest, Mater of Social and Healthcare Service. Bucharest, Romania (2007)
  • Residency – Internal Medicine – Yale New Haven Health Bridgeport Hospital, Bridgeport, CT (2010)
  • Fellowship – Critical Care Medicine – Stanford University, Stanford, CA (2012)
  • Fellowship – Infectious Diseases – Washington University in ST Louis, St Louis, MO (2013)
  • Fellowship – Infectious Diseases – University of New Mexico, Albuquerque, NM (2014)
Board Certifications
  • American Board of Internal Medicine
  • American Board of Internal Medicine, Subspecialty of Infectious Diseases
  • American Board of Internal Medicine, Critical Care Medicine
Recognition
  • 2003-2004, 2004-2005 Merit scholarship for academic results
  • 2004: The 8th Medical Students and Young Doctors National Congress, Bucharest, Romania:  first prize in surgical section
  • 2004: The 8th Medical Students and Young Doctors National Congress, Bucharest, Romania:  Honorable mention in preclinical sciences section
  • 2008: winner of medical knowledge national contest at American Geriatrics Society Meeting
  • 2010: recipient of travel award ATS 2010, New Orleans, LA
  • 2010: recipient of “Pasquale Perillie” Award for Outstanding Leadership and Scholarship, Yale University, Bridgeport Hospital, CT
  • 2012: recipient of travel award ATS 2012, San Francisco, CA
  • 2013: recipient of trainee award IDSA 2013, San Francisco CA
Selected Publications
  1. Race Does Not Impact Sepsis Outcomes When Considering Socioeconomic Factors in Multilevel Modeling.Vazquez Guillamet MC, Dodda S, Liu L, Kollef MH, Micek ST.Crit Care Med. 2021 Jul 13. doi: 10.1097/CCM.0000000000005217. Online ahead of print. PMID: 34259658
  2. A  Pragmatic Machine Learning Model To Predict Carbapenem Resistance.McGuire RJ, Yu SC, Payne PRO, Lai AM, Vazquez-Guillamet MC, Kollef MH, Michelson AP. Antimicrob Agents Chemother. 2021 Jun 17;65(7):e0006321. doi: 10.1128/AAC.00063-21. Epub 2021 Jun 17. PMID: 33972243
  3. Interleukin-6 Trajectory and Secondary Infections in Mechanically Ventilated Patients With Coronavirus Disease 2019 Acute Respiratory Distress Syndrome Treated With Interleukin-6 Receptor Blocker. Vazquez Guillamet MC, Kulkarni HS, Montes K, Samant M, Shaikh PA, Betthauser K, Mudd PA, Reynolds D, O’Halloran J, Lyons P, McEvoy C, Vazquez Guillamet R. Crit Care Explor. 2021 Feb 3;3(2):e0343. doi: 10.1097/CCE.0000000000000343. eCollection 2021 Feb. PMID: 33554125 Free PMC article.
  4. Next Steps in Pneumonia Severity Scores. Vazquez Guillamet MC, Kollef MH. Clin Infect Dis. 2021 Mar 15;72(6):950-952. doi: 10.1093/cid/ciaa184. PMID: 32123903
  5. Methicillin-resistant Staphylococcus aureus Nasal Screening Adds Limited Value to the Choice of Empiric Antibiotics in Community-acquired Pneumonia. Burnham JP, Kakol MK, Vazquez Guillamet MC. Clin Infect Dis. 2019 Mar 19;68(7):1251. doi: 10.1093/cid/ciy868. PMID: 30304410 Free PMC article. No abstract available.
  6. Predicting Resistance to Piperacillin-Tazobactam, Cefepime and Meropenem in Septic Patients With Bloodstream Infection Due to Gram-Negative Bacteria. Vazquez-Guillamet MC, Vazquez R, Micek ST, Kollef MH. Clin Infect Dis. 2017 Oct 30;65(10):1607-1614. doi: 10.1093/cid/cix612. PMID: 29020294
  7. Vazquez Guillamet C, Kollef MH. Acinetobacter Pneumonia: Improving Outcomes With Early Identification and Appropriate Therapy. Clin Infect Dis. 2018 Oct 15;67(9):1455-1462. Vazquez Guillamet MC, M Bernauer, S Micek, M Kollef. Cluster analysis to define distinct clinical phenotypes among patients with bloodstream infections. Medicine (Baltimore) 2019 Apr:98(16):e15276

Bibliography – Maria Cristina Vazquez Guillamet